Skip to main content
. 2014 Feb 5;37(4):317–324. doi: 10.1111/jvp.12101

Table 2.

Invitrogen kinase screening data

Kinase Percent inhibition at 1000 nm oclacitinib (1st replicate) Percent inhibition at 1000 nm oclacitinib (2nd replicate)
ABL tyrosine kinase 13 13
RAC-alpha serine/threonine kinase (Protein kinase B) 3 0
ZAP-70 tyrosine kinase 12 9
Angiopoietin 1 receptor (TIE-2) (TEK) 3 −1
Aurora-related kinase 1 (ARK1) 40 40
Ste20-like kinase MST2 22 14
SRC kinase 19 15
Serum glucocorticoid-regulated kinase (SGK) (SGK1) 16 11
p160ROCK protein kinase 34 32
Protein kinase C beta II Isoform 8 5
Protein kinase A alpha 19 14
Serine/threonine protein kinase PIM-2 13 6
PAK-4 (p21 activated kinase 4) 18 9
High affinity nerve growth factor receptor (TRK-A) 32 31
Serine/threonine protein kinase NEK2 4 3
Myosin light chain kinase (skeletal) 12 −1
Serine/threonine protein kinase MASK 6 3
Hepatocyte growth factor receptor (MET Proto-oncogene tyrosine kinase) 21 9
Serine/threonine protein kinase MARK 43 40
MAP kinase activated protein kinase 2 (MAPKAPK-2) 6 0
Mitogen-activated protein kinase 1 (MAPK1/ERK2) 10 6
Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4/HGK) 42 34
Proto-oncogene LCK tyrosine kinase 22 22
Vascular endothelial growth factor receptor 2 (VEGFR-2/FLK1) 41 37
Tyrosine-protein kinase JAK3 (JANUS KINASE 3) 98 92
Insulin receptor 7 4
Glycogen synthase kinase-3 beta (GSK-3 beta) 9 8
FGFR1 FGF receptor 1 12 8
Ephrin type-A receptor 2 (ECK) 9 2
Epidermal growth factor receptor 10 6
Casein kinase II alpha prime chain (CK II) 5 3
Casein kinase 1, alpha 1 1 1
Checkpoint kinase (CHK2) 9 5
Checkpoint kinase CHK1 21 6
CDK2/Cyclin-A 11 10
Calcium/calmodulin-dependent protein kinase II alpha-B subunit 22 15
Bruton's tyrosine kinase (BTK) 8 6
TAO kinase 2 20 -2
Mitogen-activated protein kinase 14 (MAPK14/P38-alpha) 9 7